Zobrazeno 1 - 10
of 16
pro vyhledávání: '"I F, Nikiforova"'
Publikováno v:
International Journal of Cancer. 53:11-16
Sixty DNA samples from breast carcinoma (BC) patients were analyzed by Southern blot to examine certain oncogene and anti-oncogene alterations. Amplification of the HER-2 oncogene was detected in 15 tumours (25%), c-myc in 2 (3%) only and HER-1 in no
Autor:
O A, Vostriukhina, I F, Nikiforova, T A, Shtam, S L, Kantorov, V K, Kovalev, S V, Vasil'ev, K M, Pozharisskiī, V A, Lantsov
Publikováno v:
Voprosy onkologii. 44(6)
In order to compare the frequency of damage to the transforming growth factor TGF-beta receptor type II gene (RII gene) and microsatellite instability (MIN) in oncogenesis of sporadic and hereditary cancer of gastrointestinal tract (GIT), 4 groups of
Autor:
O A, Vostriukhina, I F, Nikiforova, T A, Shtam, S L, Kantorov, K Iu, Tutaev, A R, Shumakov, S V, Komissarova, V P, Kalinovskiĭ, S V, Vasil'ev, V K, Kovalev
Publikováno v:
Voprosy onkologii. 44(5)
Microsatellite instability (MIN) of human genome, i.e. instability of very short (1-5 nt) DNA tandem repeats, points to a deficiency in the mismatch repair system (MMR). To investigate the role of MMR in sporadic and hereditary carcinogenesis in the
Publikováno v:
Molekuliarnaia biologiia. 29(5)
Autor:
E N, Imianitov, O I, Chernitsa, I F, Nikiforova, O M, Serova, S I, Sokolov, O Iu, Laur, A V, Togo, P G, Kniazev
Publikováno v:
Molekuliarnaia biologiia. 27(4)
Amplification of oncogenes erbb-2, erbb-1, c-myc and losses of heterozygosity (LOH) at chromosomes 11p (probe hras-1), 17p (probe ynz-22) and 17q (probe thh-59) were studied in 165 human tumours (60 breast, 22 ovary, 40 colorectal, 23 lung, and 20 th
Autor:
P G, Kniazev, E N, Imianitov, O I, Chernitsa, I F, Nikiforova, V I, Babenko, S, Bruderliaĭn, O V, Plutalo, A I, Kuz'min, O K, Kaboev, Iu A, Berlin
Publikováno v:
Molekuliarnaia biologiia. 26(5)
Abnormalities of some oncogenes, antioncogenes and losses of heterozygosity (LOH) of chromosome 11p, 17p, and 17q in colorectal carcinomas (CC) was studied. Amplification of ERBB-1/HER-1 oncogene was detected in 2 of 56 cases; ERBB-2/HER-2- in 4 of 6
Publikováno v:
Voprosy onkologii. 38(6)
The occurrence of ERBB-2 (HER-2/NEU) oncogene amplification was studied in 203 DNA samples obtained from 175 cancer patients. Amplification of ERBB-2 oncogene was established in 14 out of 63 (22%) patients with breast cancer, 1 out of 23 cases of ova
Autor:
I. F. Nikiforova, P. G. Knyazev, V. I. Babenko, O. V. Plutalov, U. A. Berlin, O. M. Serova, A. A. Goltzov, G. F. Pluzhnikova, E. I. Scwartz
Publikováno v:
Modern Trends in Human Leukemia IX ISBN: 9783540543602
It is widely accepted that tumor development and progression are due to illegitimate activation of cellular oncogenes by point mutation, retroviral insertion, chromosomal translocation and amplification or deletion of the gene [1–3]. Nonrandom dele
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::99e839df1d55d9a221f00c1e854b690c
https://doi.org/10.1007/978-3-642-76829-3_40
https://doi.org/10.1007/978-3-642-76829-3_40
Publikováno v:
Voprosy meditsinskoi khimii. 37(6)
Length polymorphism of restriction fragments of oncogene HRASI was studied in 52 patients with lung cancer as compared with corresponding normal tissues and leukocytes of these patients and of healthy volunteers. Enhanced frequency of one of main all
Publikováno v:
Voprosy onkologii. 37(6)
Size and frequency of rare alleles of HRAS1 protooncogene were studied in 258 patients with various neoplasms and 32 healthy donors of the northwestern region of the USSR. Literature data on distribution of rare alleles of certain size in sick and he